Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r

dc.contributor.author	Antela López, Antonio
dc.date.accessioned	2017-06-07T07:23:35Z
dc.date.available	2017-06-07T07:23:35Z
dc.date.issued	2014
dc.identifier.issn	1473-3099
dc.identifier.uri	http://hdl.handle.net/20.500.11940/5888
dc.language.iso	eng
dc.title	Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r
dc.type	Artigo	es
dc.authorsophos	Pozniak, A.
dc.authorsophos	Markowitz, M.
dc.authorsophos	Mills, A.
dc.authorsophos	Stellbrink, H. J.
dc.authorsophos	Antela, A.
dc.authorsophos	Domingo, P.
dc.authorsophos	Girard, P. M.
dc.authorsophos	Henry, K.
dc.authorsophos	Nguyen, T.
dc.authorsophos	Piontkowsky, D.
dc.authorsophos	Garner, W.
dc.authorsophos	White, K.
dc.authorsophos	Guyer, B.
dc.identifier.doi	10.1016/S1473-3099(14)70796-0
dc.identifier.isi	337990800031
dc.identifier.pmid	24908550
dc.identifier.sophos	14929
dc.issue.number	7
dc.journal.title	LANCET INFECTIOUS DISEASES
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Medicina Interna
dc.page.initial	590
dc.page.final	9
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	14

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.